Skip to main content
LIPO logo

LIPO · Lipella Pharmaceuticals Inc.

$0.03 +0.00 (+0.00%) At close · Jul 29
Market Cap
$152,487
Shares
4.62M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
16/100
Short interest 0.1% of shares — P16 Days to cover 1.0 — P13 Price vs VWAP -58.5% — P3 Short interest change +0.1% — P51 Worst FTD 0.00% of shares — P6

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-08-14 Scheduled
FINRA publishes Aug 25
2026-07-31 Scheduled
FINRA publishes Aug 11
2026-07-15 2,513 2,511 +2 1.00
2026-06-30 2,511 2,509 +2 1.00
2026-06-15 2,509 2,496 +13 1.00
2026-05-29 2,496 2,599 -103 1.00
2026-05-15 2,599 2,591 +8 1.00
2026-04-30 2,591 2,590 +1 1.00
2026-04-15 2,590 2,579 +11 1.00
2026-03-31 2,579 2,578 +1 1.00
2026-03-13 2,578 2,577 +1 1.39
2026-02-27 2,577 2,577 0 1.00
2026-02-13 2,577 2,575 +2 1.00
2026-01-30 2,575 2,613 -38 1.00
2026-01-15 2,613 2,515 +98 1.00
2025-12-31 2,515 2,700 -185 1.00
2025-12-15 2,700 4,816 -2,116 1.00
2025-11-28 4,816 7,003 -2,187 1.00
2025-11-14 7,003 3,053 +3,950 1.00
2025-10-31 3,053 2,620 +433 1.00
2025-10-15 2,620 2,620 0 1.00
2025-09-30 2,620 2,653 -33 1.00
2025-09-15 2,653 2,652 +1 1.00
2025-08-29 2,652 3,926 -1,274 1.00
2025-08-15 3,926 2,854 +1,072 1.00
2025-07-31 2,854 2,882 -28 1.00
Showing 1–24 of 24 settlements
Key facts CIK 1347242 CUSIP 53630L209 Visit website Investor relations